Capital Performance Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.37M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$920K |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$725K |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$662K |
| 5 |
Apple
AAPL
|
+$578K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$518K |
| 2 |
Johnson & Johnson
JNJ
|
+$318K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$273K |
| 4 |
Advanced Micro Devices
AMD
|
+$212K |
| 5 |
Cigna
CI
|
+$201K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.18% |
| 2 | Financials | 3.82% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Communication Services | 1.88% |
| 5 | Healthcare | 1.24% |
Similar funds
Capital Performance Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Capital Performance Advisors held 2,902 positions worth $313M, down 4.9% from $329M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Capital Performance Advisors withdrew a net $18.2M in Q4 2024, closing 2,725 positions and reducing 24 holdings. Its most notable exit was Johnson & Johnson, an estimated $318K position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Capital Performance Advisors added an estimated $1.37M to NVIDIA.
- Capital Performance Advisors added most to NVIDIA in Q4 2024, an estimated $1.37M increase.
- Capital Performance Advisors's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $518K.
- Capital Performance Advisors fully exited Johnson & Johnson in Q4 2024, selling an estimated $318K.
- Capital Performance Advisors's ten largest holdings make up 65% of its $313M portfolio in Q4 2024.
- Capital Performance Advisors opened 5 new positions and closed 2,725 in Q4 2024.
- Capital Performance Advisors's portfolio value fell 4.9% quarter-over-quarter to $313M.
Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.